Headline

The latest stories from AHA Today.

AHA voiced support for the Healthcare Workforce Resilience Act (H.R. 2255/S. 1024), bipartisan legislation that would expedite the visa authorization process for qualified international nurses to support hospitals facing staffing shortages. 
The Government Accountability Office named five new members to the Medicaid and CHIP Payment and Access Commission, which advises Congress on issues affecting Medicaid and the Children’s Health Insurance Program. 
With the country in the grips of an opioid epidemic, Norton Healthcare in 2015 launched the Maternal Opiate and Substance Treatment program, which makes it easy and non-stigmatizing for pregnant women with substance use disorder to access addiction treatment during obstetrical care, dramatically…
As part of the Asian American and Pacific Islander Week of Action May 3-7, the Department of Health and Human Services has partnered with the AHA and other national organizations to inform this population through social media about the special enrollment period available through Aug. 15 at the…
On this AHA Advancing Health podcast, Akin Demehin and Caitlin Gillooley, who lead AHA’s work on policy regarding quality measurement, and Anthony Weiss, M.D., senior vice president and chief medical officer of Beth Israel-Deaconness Medical Center in Boston, Mass., discuss the Centers for Medicare…
Eleven organizations representing physicians and hospitals, including the AHA, urged Health and Human Services Secretary Xavier Becerra to reconsider certain quality reporting changes to the Medicare Shared Savings Program, which the Centers for Medicare & Medicaid Services finalized in the…
The COVID-19 pandemic’s disproportionate impact on Black Americans, Native American tribes and tribal populations, Latino Americans and other communities of color is generating a renewed focus on advancing health equity.
The National Institute for Occupational Safety and Health today revoked its public health certificate of approval for Plastikon Industries’ PLASMA N95-01 filtering facepiece respirator for failure to meet filter efficiency requirements in a product audit.
Pfizer Inc. said during its quarterly earnings call that it will file by the end of May for full Food and Drug Administration approval for its COVID-19 vaccine. More than 131 million doses of the Pfizer vaccine have been administered in the U.S. since it was authorized for emergency use in December…
The Centers for Disease Control and Prevention joined the global public health community in marking the end of the Ebola outbreak in the Democratic Republic of the Congo’s North Kivu Province, 42 days after the last survivor tested negative for the virus.